Aarti Pharmalabs Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '24 Jun 30, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Cash & Equivalents	-	239.23	121.21	832.73	2.5	2.5
Trading Asset Securities	-	703.94	509.9	-	-	-
Cash & Short-Term Investments	943.17	943.17	631.11	832.73	2.5	2.5
Cash Growth	49.28%	49.44%	-24.21%	33209.36%	0%	-
Accounts Receivable	-	5,193	4,501	3,767	-	-
Other Receivables	-	143.04	53.71	65.42	-	-
Receivables	-	5,349	4,567	3,893	-	-
Inventory	-	6,429	6,020	4,755	-	-
Prepaid Expenses	-	61.48	23.25	41.96	-	-
Other Current Assets	-	674.18	388.04	758.89	-	-
Total Current Assets	-	13,456	11,630	10,281	2.5	2.5
Property, Plant & Equipment	-	10,932	9,861	9,453	-	-
Long-Term Investments	-	367.8	355.25	322.26	-	-
Goodwill	-	17.81	17.81	17.81	-	-
Other Intangible Assets	-	752.74	398.5	223.65	-	-
Other Long-Term Assets	-	235.89	119.32	100.67	-	-
Total Assets	-	25,821	22,440	20,399	2.5	2.5
Accounts Payable	-	3,783	3,395	2,146	0.03	-
Accrued Expenses	-	152.57	143.44	87.83	-	-
Short-Term Debt	-	2,641	2,142	3,377	0.17	-
Current Portion of Long-Term Debt	-	-	-	3.42	-	-
Current Portion of Leases	-	44.91	4.45	12.44	-	-
Current Income Taxes Payable	-	-	35.15	75	-	-
Other Current Liabilities	-	322.59	286.65	104.8	0.02	-
Total Current Liabilities	-	6,944	6,006	5,807	0.22	-
Long-Term Debt	-	0.39	1.84	5.55	-	0.19
Long-Term Leases	-	166.59	5.32	15.32	-	-
Long-Term Deferred Tax Liabilities	-	1,079	788.38	706.7	-	-
Other Long-Term Liabilities	-	54.41	48.14	-	-	-
Total Liabilities	-	8,251	6,855	6,534	0.22	0.19
Common Stock	-	453.13	453.13	2.5	2.5	2.5
Additional Paid-In Capital	-	4,403	4,403	4,403	-	-
Retained Earnings	-	11,734	9,746	8,006	-0.22	-0.19
Comprensive Income & Other	-	979.81	982.06	1,453	-	-
Shareholders' Equity	17,570	17,570	15,585	13,865	2.28	2.31
Total Liabilities & Equity	-	25,821	22,440	20,399	2.5	2.5
Total Debt	2,853	2,853	2,153	3,414	0.17	0.19
Net Cash (Debt)	-1,909	-1,909	-1,522	-2,581	2.33	2.31
Net Cash Growth	-	-	-	-	0.59%	-
Net Cash Per Share	-21.06	-21.07	-16.79	-28.48	9.31	9.25
Filing Date Shares Outstanding	90.61	90.63	90.63	90.63	0.25	0.25
Total Common Shares Outstanding	90.61	90.63	90.63	90.63	0.25	0.25
Working Capital	-	6,513	5,624	4,475	2.28	2.5
Book Value Per Share	193.88	193.88	171.97	152.99	9.12	9.25
Tangible Book Value	16,800	16,800	15,169	13,623	2.28	2.31
Tangible Book Value Per Share	185.38	185.38	167.38	150.32	9.12	9.25
Land	-	779.38	669.32	641.01	-	-
Buildings	-	1,668	1,568	1,202	-	-
Machinery	-	12,789	11,610	9,941	-	-
Construction In Progress	-	784.97	622.04	1,652	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.